Professor
University of North Carolina at Chapel Hill
Dr. Paul B. Watkins is the Howard Q Ferguson Distinguished Professor at the University of North Carolina – Chapel Hill. He is a clinical hepatologist and also an accomplished basic and translational investigator in the fields of drug metabolism and hepatotoxicity. He is the recipient of numerous honors and awards including the 2013 Agilent Therapeutic Frontiers Award, the 2015 Rawls-Palmer Award for Progress in Medicine from the American Society for Clinical Pharmacology and Therapeutics, the 2018 Career Award from the Toxicology Section of the American Society for Clinical Pharmacology and Experimental Therapeutics, and the 2023 Distinguished Scientist Award from the American College of Toxicology. He is also the founder of the DILI-sim Initiative which is a public- private consortium developing a quantitative systems toxicology (QST) model to explain and predict liver safety liabilities of new drug candidates. Dr. Watkins currently co-chairs the Steering Committee and chairs the Genetics Committee for the U.S. Drug Induced Liver Injury Network funded by the National Institutes of Health. He is also a current member of a Reagan-Udall Foundation committee advising the FDA on novel alternative methods to minimize animal use in drug development and contact Principal Investigator of the Triangle Center of Excellence in Regulatory Science (CERSI) funded by the FDA.
Disclosure(s): No financial relationships to disclose
Rawls-Palmer Progress in Medicine Award Lecture
Friday, March 29, 2024
1:30 PM – 2:15 PM MDT